[CHRS] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 68.04%
YoY- 54.84%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 123,856 111,684 83,433 37,098 0 0 0 -
PBT 41,271 47,890 23,618 -20,004 -62,596 -58,826 -43,685 -
Tax 2,044 847 51 5,027 70 2,978 6,012 -51.19%
NP 39,227 47,043 23,567 -20,004 -62,596 -58,808 -43,638 -
Tax Rate -4.95% -1.77% -0.22% - - - - -
Total Cost 84,629 64,641 59,866 57,102 62,596 58,808 43,638 55.32%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 31.67 42.12 28.25 -53.92 0.00 0.00 0.00 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS 0.56 0.67 0.34 -0.29 -0.92 -0.87 -0.68 -
EPS Diluted 0.53 0.63 0.32 -0.29 -0.92 -0.87 -0.68 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.